Not yet recruitingInterventionalPhase 2Last updated Aug 10, 2026

A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Chronic Rhinosinusitis With Nasal Polyps

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Study Evaluating the Efficacy and Safety of AK139 in Participants With Chronic Rhinosinusitis With Nasal Polyps

Overview

ClinicalTrials.gov ID: NCT07755371
Lead Sponsor: AkesoINDUSTRY
Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy, safety, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of AK139 injection compared with placebo in participants with chronic rhinosinusitis with nasal polyps (CRSwNP) receiving background treatment with mometasone furoate nasal spray (MFNS).
Study Type

Status

Overall Status: Not yet recruiting
Start Date: Aug 10, 2026Estimated
Primary Completion Date: Apr 30, 2027Estimated
Completion Date: Jul 31, 2027Estimated

Study Record Dates

First Submitted: Aug 5, 2026
First Submitted that Met QC Criteria: Aug 5, 2026
First Posted: Aug 10, 2026Actual
Last Update Submitted that Met QC Criteria: Aug 5, 2026
Last Update Posted: Aug 10, 2026Actual
Last Verified: Aug 2026

NCT07313917Not yet recruiting

A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

NCT05873803Unknown status

The Study of GR1802 in Patients with Chronic Rhinosinusitis with Nasal Polyps

NCT04805398Completed

Subcutaneously CM310/Placebo in Patients With Chronic Rhinosinusitis With Nasal Polyposis (CROWNS-1)

NCT05891483Completed

Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps

NCT06372678Unknown status

Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis

NCT07132827Recruiting

Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps